SAN FRANCISCO (AP) -- A British pharmaceutical company is working its way toward FDA approval for the world's first prescription drug developed from raw marijuana instead of synthetic equivalents, a medical milestone that could presage a new era for the plant and the nation's uneasy relationship with it.
GW Pharma has developed a mouth spray called Sativex that contains marijuana's two best known components--delta 9-THC and cannabidiol. It's already been approved in Canada, New Zealand and eight European countries for relieving muscle spasms associated with multiple sclerosis.
The company is in advanced clinical trials to get its product approved in the United States as a treatment for severe cancer pain. It hopes to seek clearance from the U.S. Food and Drug Administration to put it on pharmacy shelves by the end of next year.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.